CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sunflower Pharmaceutical Group Co Ltd Company Snapshot
Sunflower Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sunflower Pharmaceutical Group Co Ltd with three other companies in this sector in China: Jinling Pharmaceutical Company Limited (2016 sales of 3.58 billion Chinese Renmimbi [US$555.75 million] of which 73% was Medicine Manufacture), Renhe Pharmacy Company Limited (3.57 billion Chinese Renmimbi [US$554.12 million] of which 99% was Medicine), and Sihuan Pharmaceutical Holdings Group Ltd (3.19 billion Chinese Renmimbi [US$494.90 million] of which 100% was Pharmaceutical Prods).

Sales Analysis. Sunflower Pharmaceutical Group Co Ltd reported sales of 3.36 billion Chinese Renmimbi (US$522.07 million) for the year ending December of 2016. This represents an increase of 10.8% versus 2015, when the company's sales were 3.03 billion Chinese Renmimbi. Sales at Sunflower Pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 116%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 282.2% in 2016, from 19.37 million Chinese Renmimbi to 74.04 million Chinese Renmimbi. Not all segments of Sunflower Pharmaceutical Group Co Ltd experienced an increase in sales in 2016: sales of Headquarter fell 3.6% to 6.89 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sunflower Pharmaceutical Group Co Ltd
  Stock Performance Chart for Sunflower Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 33.46
(Figures in Chinese Renmimbi)
1 Week 3.5%   13 Weeks 7.4%  
4 Weeks -6.0%   52 Weeks -1.2%  
 
Sunflower Pharmaceutical Group Co Ltd Key Data:
  Ticker: 002737 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 3,360,620,334
(Year Ending Jan 2017).
Employees: 5,553
  Currency: Chinese Renmimbi Market Cap: 9,770,320,000
  Fiscal Yr Ends: December Shares Outstanding: 292,000,000
  Share Type: A Gu Closely Held Shares: 196,874,047
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.